Cargando…
Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor
BACKGROUND: Successful colorectal cancer (CRC) therapy often depends on the accurate identification of primary tumours with invasive potential. There is still a lack of identified pathological factors associated with disease recurrence that could help in making treatment decisions. Neuromedin U (NMU...
Autores principales: | Przygodzka, Patrycja, Sochacka, Ewelina, Soboska, Kamila, Pacholczyk, Marcin, Papiewska-Pająk, Izabela, Przygodzki, Tomasz, Płociński, Przemysław, Ballet, Steven, De Prins, An, Boncela, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422652/ https://www.ncbi.nlm.nih.gov/pubmed/34493299 http://dx.doi.org/10.1186/s13046-021-02073-8 |
Ejemplares similares
-
Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment
por: Przygodzka, Patrycja, et al.
Publicado: (2022) -
Neuromedin U: A Small Peptide in the Big World of Cancer
por: Przygodzka, Patrycja, et al.
Publicado: (2019) -
Erratum: Neuromedin U: A Small Peptide in the Big World of Cancer. Cancers 2019, 11, 1312
por: Przygodzka, Patrycja, et al.
Publicado: (2020) -
Implications of ABCC4–Mediated cAMP Efflux for CRC Migration
por: Kryczka, Jakub, et al.
Publicado: (2020) -
Regulation of miRNAs by Snail during epithelial-to-mesenchymal transition in HT29 colon cancer cells
por: Przygodzka, Patrycja, et al.
Publicado: (2019)